On the surface, chronic kidney disease-associated pruritus is just an itch. But for patients living with CKD-associated pruritus, the consequences are much more.1-6

Browse further to discover how CKD-aP may be affecting your patients’ quality of life,  mental health and even life expectancy.1–6

Are your patients
suffering in silence?
Up to 67% of haemodialysis patients are suffering from CKD-associated pruritus6

Your haemodialysis patients may be suffering in silence with CKD-aP.6 Learn about CKD-aP to help understand an important concern about their haemodialysis.7


Still, there are times when my itching feels overpowering, when I say to myself it’s really terrible right now.”

– CKD-aP patient on haemodialysis, Germany

When CKD-associated pruritus becomes more than just an itch
The itch with life-changing consequences

CKD patients undergoing haemodialysis already have a poor quality of life, which is exacerbated by CKD-associated pruritus.1–3 Uncover how CKD-aP could be affecting your haemodialysis patients’ sleep quality, social relationships and mental health.


I’m scratching all the time, you can’t help it. I can’t sleep at night because it’s there twenty-four hours a day.”

– CKD-aP patient on haemodialysis, UK

The impact of CKD-associated pruritus lies beneath the surface
The impact of CKD-associated pruritus lies beneath the surface

CKD-aP can have a serious impact on health outcomes as well as higher drug utilisation.1,5,6 Look beneath the surface to discover the consequences of CKD-aP.


Sometimes I could just literally scratch myself to death”

– CKD-aP patient on haemodialysis, Australia

Treatment options
Managing CKD-associated pruritus - a challenge worth taking on

Management of CKD-aP, should be an essential part of treatment for all patients undergoing haemodialysis and suffering from CKD-aP.8 Help your patients make informed choices about their treatment options for CKD-aP.


The real challenge was to find the treatment that worked for me”

– CKD-aP patient on haemodialysis, Australia

References & footnotes
  1. Ramakrishnan K, Bond TC, Claxton A, et al. Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis. (2013);7:1–12.
  2. Shirazian S, Aina O, Park Y, et al. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis. (2017);10:11–26.
  3. Tsai YC, Hung CC, Hwang SJ, et al. Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant. (2010);25:1621–1626.
  4. Pisoni R, Wikström B,  Elder S, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. (2006);21:3495–3505.
  5. Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. (2006);69(9):1626–1632.
  6. Sukul N, Karaboyas A, Csomor P, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Medicine. (2020);3(1):42–53.e1.
  7. Yosipovitch G,  Zucker I,  Boner G, et al. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol. (2001);81:108–111.
  8. Millington G,  Collins A,  Lovell C, et al. British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018. Br J Dermatol. (2018);178(1):34–60.